Cantor Fitzgerald Reiterates Overweight on SI-BONE, Maintains $25 Price Target
Benzinga Newsdesk 1 year ago
NewsPrice TargetReiterationAnalyst Ratings
Cantor Fitzgerald analyst Ross Osborn reiterates SI-BONE (NASDAQ:SIBN) with a Overweight and maintains $25 price target.
Cantor Fitzgerald analyst Ross Osborn reiterates SI-BONE (NASDAQ:SIBN) with a Overweight and maintains $25 price target.